Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma

doi:10.3748/wjg.v6.i4.565

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1375)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

140

HTML

953

Figures (1-2)

162

Tables (1-1)

120

Sum=1375

Aug 15, 2000 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 15, 2000; 6(4): 565-568
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.565

Open in New Tab Full Size Figure Download Figure

Figure 1 Serum VEGF levels in benign liver tumor and HCC (hepa tocellular carcinoma) groups.

Open in New Tab Full Size Figure Download Figure

Figure 2 Serum VEGF levels in HTMR and LTMR groups. HTMR: high-tendency metastatic recur rence group; LTMR: low tendency metastatic recurrence group.

Citation: Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 2000; 6(4): 565-568
URL: https://www.wjgnet.com/1007-9327/full/v6/i4/565.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i4.565